Calcitonin stimulation: pentagastrin vs. calcium gluconate - potency, feasibility and tolerance in chronic kidney disease. - CT- stimulation in CKD

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-002863-84-AT

Enrollment

Registered

2012-01-19

Start date

2012-03-02

Completion date

Unknown

Last updated

2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

investigation of the presence/absence of C-cell abnormalities of the thyroid in chronic kidney disease.

Interventions

Trade Name: Pentagastrin Product Name: Peptavlon Pharmaceutical Form: Injection INN or Proposed INN: PENTAGASTRIN CAS Number: 5534-95-2 Current Sponsor code: - Other descriptive name: - Concentration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: > 18 years; at least 3 months of chronic dialysis treatment (hemodiyalisis, peritoneal dialysis) Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 15 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 5

Exclusion criteria

Exclusion criteria: Cardiovascular interventions in the last 12 months; infarction; instable coronary heart disease; atrial fibrillation; cardiomyopath;, asthma; COPD (late stage); epilepsy; thyroidectomy; pregnancy; alcoholism; digitalis treatment;

Design outcomes

Primary

Measure	Time frame
Main Objective: Comparison of the two calcitonin stimulation tests pentagastrin and calcium gluconate regarding potency, feasibility and tolerance.;Secondary Objective: ;Primary end point(s):	—

Countries

Austria

Contacts

Public ContactAKH, Nephrologie-Dr.Kyra Borchhardt

Medizinische Universitaet Wien, AKH Wien, Innere Medizin III, klin.Abteilung fuer Nephrologie und Dialyse

kyra.borchhardt@meduniwien.ac.at431404004390

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026